Invesco India Contra Fund

Direct · Growth
₹156.72
18 Jun 2026
NAV
19.0%
3Y CAGR
18.4%
5Y CAGR
18.7%
10Y CAGR
19.0%
Weighted CAGR
?
7.51
Sharpe
-36.5%
Max Drawdown
?
NA
TER

If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.

Duration Invested Median Value XIRR Min XIRR Max XIRR
1 Year₹12.00 L₹12.97 L22.9%-53.9%109.5%
3 Years₹36.00 L₹47.46 L18.7%-19.1%38.9%
5 Years₹60.00 L₹93.47 L18.1%-4.8%32.0%
7 Years₹84.00 L₹1.55 Cr17.8%3.8%26.0%
10 Years₹1.20 Cr₹3.13 Cr18.4%14.6%22.4%
12 Years₹1.44 Cr₹4.73 Cr18.4%14.9%21.4%

SIP returns vs benchmark & category

Annualised SIP return (XIRR) over each rolling horizon — like-for-like, not lump-sum.

Duration Fund SIP XIRR NIFTY 50 Category avg Fund edge
1 Year22.9%14.5%21.3%+8.4%
3 Years18.7%11.2%18.3%+7.5%
5 Years18.1%10.4%18.2%+7.7%
7 Years17.8%10.6%18.2%+7.2%
10 Years18.4%11.5%19.1%+6.9%
12 Years18.4%11.4%18.4%+7.0%

Duration Mean Median Min Max Sharpe Sortino % Positive Cat. Mean Cat. Median
1 Year22.0%16.6%-30.4%96.5%0.683.0589%
3 Years19.0%19.5%-2.8%37.0%2.0517.26100%
5 Years18.4%18.3%2.4%31.4%2.1856.41100%
10 Years18.7%18.4%15.0%22.2%7.51100%

-36.5%
Max Drawdown
1 mo
Drawdown Duration
8 mo
Recovery Time
-5.0%
Avg Drawdown

Calmar Ratio by Duration

0.60
1Y
0.52
3Y
0.50
5Y
0.48
7Y
0.51
10Y
0.55
12Y

Compared against NIFTY 50

Duration Alpha Beta Upside Capture Downside Capture Fund CAGR Bench CAGR
1 Year+3.611.08106.9%102.4%0.3%-2.6%
3 Years+8.671.03106.3%95.7%17.6%8.8%
5 Years+6.410.9899.5%91.9%15.4%9.0%
7 Years+6.450.9497.2%90.6%17.1%10.9%
10 Years+5.770.9598.9%92.5%16.9%11.4%
12 Years+6.760.9598.0%90.3%16.7%10.2%
15 Years+6.200.9296.6%88.8%15.7%9.7%

68
Total Holdings
35.1%
Top 10 Weight
25
Sectors
# Stock % of NAV
1Larsen & Toubro Limited5.24%
2ICICI Bank Limited5.04%
3Axis Bank Limited3.78%
4HDFC Bank Limited3.65%
5Reliance Industries Limited3.60%
6Mahindra & Mahindra Limited3.55%
7Infosys Limited3.22%
8Bharti Airtel Limited2.56%
9Cholamandalam Investment and Finance Company Limited2.35%
10Glenmark Pharmaceuticals Limited2.11%